8-KOther Events

CSX CORP 8-K Report, Corporate Update (May 19, 2017)

Filed May 19, 2017For Securities:CSX

Summary

This 8-K filing from CSX Corporation addresses a Wall Street Journal article published on May 17, 2017, concerning the health of its CEO, E. Hunter Harrison. The article quotes Mr. Harrison discussing his health, including experiencing shortness of breath and using oxygen. He urged readers to judge him by his performance rather than his medical record. CSX Corporation, in response, stated its policy not to comment on executive health matters when performance is not in question. However, the company affirmed that Mr. Harrison remains actively and deeply involved in daily operations. Investors should note this disclosure addresses a specific media report and the company's stance on the CEO's ongoing engagement despite his reported health conditions.

Key Highlights

  • 1CSX Corp filed an 8-K on May 19, 2017, addressing a Wall Street Journal article about CEO E. Hunter Harrison's health.
  • 2The article quotes CEO E. Hunter Harrison discussing his personal health, including shortness of breath and oxygen use.
  • 3Mr. Harrison stated, 'Don’t judge me by my medical record, judge me by my performance.'
  • 4CSX's official statement notes it is company policy not to comment on executive health matters absent performance concerns.
  • 5The company affirmed that CEO E. Hunter Harrison continues to be 'actively and deeply involved on a daily basis.'
  • 6The filing's primary purpose is to address media inquiries and provide the company's official commentary on the CEO's status.

Frequently Asked Questions

This 8-K filing is primarily to address a Wall Street Journal article published on May 17, 2017, which reported on the health of CSX's CEO, E. Hunter Harrison, and included his direct quotes regarding his condition and performance.

Mr. Harrison was quoted in The Wall Street Journal saying he was 'running on so much adrenaline that no one can stop me' and that investors should 'judge me by my performance.' He also mentioned experiencing shortness of breath for which he uses oxygen, and a cough that oxygen helps alleviate.

CSX stated that as a matter of policy, they do not comment on the health of executives unless performance is an issue. They also explicitly confirmed that CEO E. Hunter Harrison remains 'actively and deeply involved on a daily basis.'

The filing acknowledges the CEO's reported health issues but emphasizes his continued deep involvement in daily operations and his focus on performance. Investors should consider this information in conjunction with the company's statements about his ongoing engagement and the CEO's own directive to judge based on performance.